Differential Effects of Dietary Fat Content and Protein Source on Bone Phenotype and Fatty Acid Oxidation in Female C57Bl/6 Mice

Background Glycomacropeptide (GMP) is a 64-amino acid glycophosphopeptide released from κ-casein during cheesemaking that promotes satiety, reduces body fat, increases bone mass and infers prebiotic and anti-inflammatory effects. The impact of adiposity and gender on bone health is unclear. Objective To determine how feeding female mice diets providing 60% Fat Kcal (high-fat) or 13% Fat Kcal (control) with either GMP or casein as the protein source impacts: body composition, ex vivo fatty acid oxidation, bone (femoral) biomechanical performance, and the relationship between body composition and bone. Methods Weanling female C57Bl/6 mice were fed high-fat (60% Fat Kcal) or control diets (13% Fat Kcal) with GMP or casein from 3 to 32 weeks of age with assessment of body weight and food intake. Body composition was assessed by dual-energy X-ray absorptiometry (DXA). Fatty acid oxidation was measured in liver, muscle, and fat tissues using 14C-palmitate. Plasma concentrations of hormones and cytokines were determined. Bone biomechanical performance was assessed by the 3-point bending test. Results Female mice fed high-fat diets showed increased fatty acid oxidation capacity in both gastrocnemius muscle and brown adipose tissue compared to mice fed the control diets with a lower fat content. Despite increased fat mass in mice fed the high-fat diets, there was little evidence of glucose impairment or inflammation. Mice fed the high-fat diets had significantly greater total body bone mineral density (BMD), femoral BMD, and femoral cross-sectional area than mice fed the control diets. Femora of mice fed the high-fat diets had increased yield load and maximum load before fracture, consistent with greater bone strength, but reduced post-yield displacement or ductility, consistent with bone brittleness. Female mice fed a high-fat GMP diet displayed increased fat oxidation capacity in subcutaneous fat relative to mice fed the high-fat casein diet. Regardless of dietary fat content, GMP increased total body bone mineral content and femur length. The prebiotic properties of GMP may mediate the beneficial effects of GMP on bone. Conclusions Female mice adapt to high-fat feeding by increasing oxidative capacity in muscle tissue and to a lesser extent brown adipose tissue. High-fat feeding in female mice leads to development of a bone phenotype where femora show increased BMD and are stronger, yet more brittle. The increased brittleness of bone was associated with increased body fat content due to high-fat feeding. In summary, high-fat feeding in female mice increases mineralization of bone, but negatively impacts bone quality resulting in brittle bones.

[1]  J. Steele,et al.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[2]  Jianping Ye,et al.  Sodium butyrate epigenetically modulates high‐fat diet‐induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning , 2015, British journal of pharmacology.

[3]  L. Forzani,et al.  Administration of caseinomacropeptide-enriched extract to mice enhances the calcium content of femur in a low-calcium diet , 2015 .

[4]  D. Ney,et al.  Dietary Protein Source Impacts Bone, Acid Load and Calcium Excretion in Murine and Human Phenylketonuria , 2015 .

[5]  K. Sjögren,et al.  Effects of the gut microbiota on bone mass , 2015, Trends in Endocrinology & Metabolism.

[6]  Jeroen A. A. Demmers,et al.  Proteomic signatures of extracellular vesicles secreted by nonmineralizing and mineralizing human osteoblasts and stimulation of tumor cell growth , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  R. Trivedi,et al.  Micro-architectural changes in cancellous bone differ in female and male C57BL/6 mice with high-fat diet-induced low bone mineral density. , 2014, The British journal of nutrition.

[8]  X. Mao,et al.  Ameliorating effects of casein glycomacropeptide on obesity induced by high-fat diet in male Sprague-Dawley rats. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  K. Petersen,et al.  Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. , 2013, Endocrinology.

[10]  V. Holcomb,et al.  Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance , 2012, European Journal of Nutrition.

[11]  P. Carlsson,et al.  Female Mice are Protected against High-Fat Diet Induced Metabolic Syndrome and Increase the Regulatory T Cell Population in Adipose Tissue , 2012, PloS one.

[12]  D. Ney,et al.  Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide Diet , 2012, PloS one.

[13]  D. Ney,et al.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria. , 2012, Journal of the Academy of Nutrition and Dietetics.

[14]  B. Spiegelman,et al.  Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human , 2012, Cell.

[15]  D. Ney,et al.  Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria. , 2012, American journal of physiology. Endocrinology and metabolism.

[16]  E. Orwoll,et al.  Obesity and fracture in men and women: An epidemiologic perspective , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  Andrea P. Clavijo,et al.  Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. , 2011, Journal of agricultural and food chemistry.

[18]  R. Vanderby,et al.  Linkage mapping of principal components for femoral biomechanical performance in a reciprocal HCB-8 × HCB-23 intercross. , 2011, Bone.

[19]  William N. Venables,et al.  Modern Applied Statistics with S , 2010 .

[20]  P. Requena,et al.  Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis. , 2010, The Journal of nutrition.

[21]  I. Reid Fat and bone. , 2010, Archives of biochemistry and biophysics.

[22]  D. Ney,et al.  Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria. , 2010, Molecular genetics and metabolism.

[23]  P. Guilloteau,et al.  Is caseinomacropeptide from milk proteins, an inhibitor of gastric secretion? , 2010, Regulatory Peptides.

[24]  M. Ibrahim Subcutaneous and visceral adipose tissue: structural and functional differences , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[25]  Robert V Farese,et al.  SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation , 2009, Nature.

[26]  S. Mittelman,et al.  Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. , 2009, The Journal of clinical endocrinology and metabolism.

[27]  R. Vanderby,et al.  Quantitative trait loci for biomechanical performance and femoral geometry in an intercross of recombinant congenic mice: restriction of the Bmd7 candidate interval , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  K. Strissel,et al.  Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. , 2009, Endocrinology.

[29]  M. Westerterp-Plantenga,et al.  Effects of complete whey-protein breakfasts versus whey without GMP-breakfasts on energy intake and satiety , 2009, Appetite.

[30]  M. Febbraio,et al.  Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet–Induced Insulin Resistance , 2009, Diabetes.

[31]  P. Moughan,et al.  The influence of whey protein and glycomacropeptide on satiety in adult humans , 2009, Physiology & Behavior.

[32]  Y. Kim,et al.  Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. , 2008, Nutrition.

[33]  P. Clifton,et al.  Whey protein isolate and glycomacropeptide decrease weight gain and alter body composition in male Wistar rats , 2008, British Journal of Nutrition.

[34]  P. Clifton,et al.  The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk. , 2008, The American journal of clinical nutrition.

[35]  A. Daddaoua,et al.  Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17 , 2008, British journal of pharmacology.

[36]  B. Burton-Freeman Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK) , 2008, Physiology & Behavior.

[37]  T. Travison,et al.  Lean Mass and Not Fat Mass Is Associated With Male Proximal Femur Strength , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  P. Chambon,et al.  Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts , 2007, Cell.

[39]  N. Turner,et al.  Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle , 2007, Diabetes.

[40]  Mone Zaidi,et al.  Skeletal remodeling in health and disease , 2007, Nature Medicine.

[41]  P. Puigserver,et al.  Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α , 2007, The EMBO journal.

[42]  S. Teitelbaum Osteoclasts: what do they do and how do they do it? , 2007, The American journal of pathology.

[43]  G. Karsenty,et al.  Convergence between bone and energy homeostases: leptin regulation of bone mass. , 2006, Cell metabolism.

[44]  R. López-Fandiño,et al.  Health effects and technological features of caseinomacropeptide , 2006 .

[45]  J. Tobias,et al.  Adipose tissue stimulates bone growth in prepubertal children. , 2006, The Journal of clinical endocrinology and metabolism.

[46]  J. Eisman,et al.  Abdominal fat and hip fracture risk in the elderly: The Dubbo Osteoporosis Epidemiology Study , 2005, BMC musculoskeletal disorders.

[47]  T. K. O'Neil,et al.  Accuracy and precision of PIXImus densitometry for ex vivo mouse long bones: comparison of technique and software version. , 2004, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[48]  W. Aimutis Bioactive properties of milk proteins with particular focus on anticariogenesis. , 2004, The Journal of nutrition.

[49]  M. Etzel,et al.  Manufacture and use of dairy protein fractions. , 2004, The Journal of nutrition.

[50]  I. Reid Relationships among body mass, its components, and bone. , 2002, Bone.

[51]  G. Cooney,et al.  Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. , 2002, Diabetes.

[52]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[53]  A. Thorburn,et al.  Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[55]  C. Steppan,et al.  Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.

[56]  C H Turner,et al.  Three rules for bone adaptation to mechanical stimuli. , 1998, Bone.

[57]  F. Levenez,et al.  Effects of gastric digestive products from casein on CCK release by intestinal cells in rat , 1994 .

[58]  David W. Scott The New S Language , 1990 .

[59]  P. Jollès,et al.  CASEINO-GLYCOPEPTIDES: CHARACTERIZATION OF A METHIONINE RESIDUE AND OF THE N-TERMINAL SEQUENCE. , 1965, Biochemical and biophysical research communications.

[60]  Karl Pearson F.R.S. LIII. On lines and planes of closest fit to systems of points in space , 1901 .

[61]  R. Shahar,et al.  Effect of peripherally administered leptin antagonist on whole body metabolism and bone microarchitecture and biomechanical properties in the mouse. , 2014, American journal of physiology. Endocrinology and metabolism.

[62]  H. J. Yoo,et al.  The differential relationship between fat mass and bone mineral density by gender and menopausal status , 2011, Journal of Bone and Mineral Metabolism.

[63]  Robert V Farese,et al.  SIRT 3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation , 2010 .

[64]  R. Ritchie,et al.  Reduced size-independent mechanical properties of cortical bone in high-fat diet-induced obesity. , 2010, Bone.

[65]  P. Clifton,et al.  Effect of glycomacropeptides (GMP) on satiety hormones and food intake , 2009 .

[66]  T. Elsasser,et al.  Epigenetic regulation of genomes: nutrient-specific modulation of genetic networks in bovine cells. , 2008, Developments in biologicals.

[67]  P. Chambon,et al.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. , 2007, Cell.

[68]  Y. Obara,et al.  Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. , 2007, Cellular signalling.

[69]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[70]  Brian D. Ripley,et al.  Modern applied statistics with S, 4th Edition , 2002, Statistics and computing.

[71]  T Hashimoto,et al.  Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. , 2001, Annual review of nutrition.

[72]  T. Hashimoto,et al.  PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .

[73]  G. Forbes,et al.  Lean body mass in obesity. , 1983, International journal of obesity.

[74]  Pei-shan Wu,et al.  Biochemical and Biophysical Research Communications , 1960, Nature.